• Full Conference Program

  • LEgend
    •  Plenary session
    •  Keynote session
    •  Oral presentation
    •  Poster sessions
    •  Break
    • Social Event
    • description Posters
    • source Topic
    • person_pin Speaker
  • 09:15 | Systemic iron homeostasis
    person_pinMLECZKO - SANECKA Katarzyna
    09:40 | Cellular iron homeostasis
    person_pinRODRIGUEZ Raphaël
    10:05 | Heme metabolism and related diseases
    person_pinCHIABRANDO Deborah
    10:50 | Iron and red cells
    person_pinNAI Antonella
    11:15 | Iron & pregnancy
    person_pinSANGKHAE Veena
    11:40 | Iron disorders in the clinic
    person_pinSTEINBICKER Andrea
    12:05 | Iron and infection
    person_pinNEMETH Elizabeta
    14:30 | ERYTHROFERRONE OVEREXPRESSION AMELIORATES ANEMIA AND ENHANCES KIDNEY FUNCTION IN A CKD MOUSE MODEL
    person_pinCZAYA Brian - Center for Iron Disorders, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, United StatestopicIron related disorders
    pageview
    14:45 | Cell-autonomous osteoclast iron deficiency leads to osteopenia
    person_pinCARVALHO OLIVEIRA Tiago - Department of Pediatric Oncology, Hematology and Immunology, University Hospital of Heidelberg, Heidelberg, GermanytopicIron related disorders
    pageview
    15:00 | ENHANCED ERYTHROPOIESIS BY HEMATOPOIETIC TFR2 DELETION CORRECTS HYPERGLYCEMIA IN β-THALASSEMIA
    person_pinDI MODICA Simona Maria - Regulation of Iron Metabolism Unit, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, ItalytopicIron related disorders
    pageview
    15:15 | COMBINING IRON RESTRICTION AND ERYTHROID MATURATION AGENTS HAS A SUPERIOR THERAPEUTIC EFFECT IN MDS
    person_pinVINCHI Francesca - New York Blood Center, New York , United StatestopicIron related disorders
    pageview
    15:30 | FERRIC CARBOXYMALTOSE INCREASES BONE FRACTURE RISK AND INHIBITS DMP1-MEDIATED αVβ3-INTEGRIN SIGNALIN
    person_pinWAGNER Sonja - Christian Doppler Laboratory for Iron and Phosphate Biology, Medical University of Innsbruck, Innsbruck, AustriatopicFerroptosis
    pageview
    15:45 | A genome-wide meta-analysis connects iron homeostasis to metabolic disease through poly-unsaturated
    person_pinLOB Heinrich - Regeneron Pharmaceuticals, Tarrytown, United StatestopicIron related disorders
    pageview
    16:30 | A NOVEL MODEL OF X-LINKED SIDEROBLASTIC ANEMIA (Alas2-KO, XLSA) WITH RING SIDEROBLAST, SEVERE ANEMIA
    person_pinRIVELLA Stefano - Children's Hospital of Philadelphia, Philadelphia, United States - University of Pennsylvania, , Philadelphia, United StatestopicErythropoiesis
    pageview
    16:45 | The role of cell extrinsic Nrf2 in hematopoietic stem cell transplantation with iron overload
    person_pinREIS Joana - i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal - ICBAS - Instituto de Ciências BIomédias Abel Salazar da Universidade do Porto, Porto, PortugaltopicErythropoiesis
    pageview
    17:00 | The effect of altitude of residence on dietary iron absorption in iron depleted women of reproductiv
    person_pinMORETTI Diego - University of Applied Sciences of South Switzerland (SUPSI) / Swiss Distance University of Applied Sciences (FFHS), Zürich, SwitzerlandtopicErythropoiesis
    pageview
    09:00 | Gut-derived erythroferrone contributes to intestinal homeostasis
    person_pinMEDJBEUR Thanina - IRSD, Université de Toulouse, INSERM, INRAE, ENVT, Univ Toulouse III - Paul Sabatier (UPS), Toulouse, FrancetopicIron and inflammatory disorders
    pageview
    09:15 | ASSESSING TRANSFERRIN RECEPTOR 2 FUNCTION IN INTESTINAL INFLAMMATION AND BONE LOSS DURING COLITIS
    person_pinLEDESMA-COLUNGA Maria G. - Department of Medicine III & Center for Healthy Aging, Medical Faculty and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, GermanytopicIron and inflammatory disorders
    pageview
    09:30 | IRON REGULATORY PROTEINS 1 AND 2 HAVE OPPOSING ROLES IN REGULATING INFLAMMATION
    person_pinMEYRON-HOLTZ Esther - Laboratory for Molecular Nutrition, Faculty of Biotechnology and Food Engineering, Technion – Israel Institute of Technology, Haifa, IsraeltopicIron and inflammatory disorders
    pageview
    09:45 | Role of cutaneous hepcidin in graft-versus-host disease (GvHD)
    person_pinCHRAYTEH Doha - Université Paris Cité, CNRS, INSERM, Institut Cochin, F-75014 Paris, FrancetopicIron and inflammatory disorders
    pageview
    10:00 | IRON ACCUMULATION AND METABOLIC CHANGES IN MONOCYTES CORRELATE WITH DISEASE SEVERITY IN SEPSIS
    person_pinMERTENS Christina - Department of Pediatric Hematology, Oncology and Immunology, Heidelberg University Hospital, Heidelberg, Germany - Center for Translational Biomedical Iron Research, Heidelberg, Germany - German Centre for Cardiovascular Research (DZHK), partner site Heidelberg/Mannheim, GermanytopicIron and inflammatory disorders
    pageview
    10:15 | ROLE OF LIPOCALIN 2 AND IRON METABOLISM IN CANCER AND GLUCOCORTICOID-INDUCED SKELETAL MUSCLE ATROPHY
    person_pinWYART Elisabeth - Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, ItalytopicIron and inflammatory disorders
    pageview
    11:30 | CONTRIBUTION OF HIF2Α IN IRON BIOAVAILABILITY AGAINST ADHERENT INVASIVE ESCHERICHIA COLI INFECTION
    person_pinFALABRÈGUE Marion - Université Paris Cité, CNRS, INSERM, Institut Cochin, , Paris, FrancetopicIron and infection
    pageview
    11:45 | IRON STATUS AND THE RISK OF SEVERE INFECTION IN AFRICAN CHILDREN
    person_pinMURIUKI John - KEMRI-Wellcome Trust Research Programme, Nairobi, KenyatopicIron and infection
    pageview
    12:00 | THE ROLE OF RIPK1 IN PREVENTING MALARIA-INDUCED NEUROINFLAMMATION
    person_pinLIMA Illyane - NOVA Medical School, Lisbon, PortugaltopicIron and infection
    pageview
    12:15 | IRON ABSORPTION, LOSSES AND GAINS IN VIRALLY-SUPPRESSED HIV+ CHILDREN
    person_pinZIMMERMANN Michael - The University of Oxford, Oxford, United KingdomtopicIron and infection
    pageview
    15:00 | LIVER SINUSOIDAL ENDOTHELIAL CELLS (LSECS) CONSTITUTE A MAJOR ROUTE FOR HEMOGLOBIN CLEARANCE
    person_pinJONCZY Aneta - International Institute of Molecular and Cell Biology in Warsaw, Warsaw, PolandtopicCellular iron
    pageview
    15:15 | IRON CHAPERONE POLY C-BINDING PROTEIN 1 REGULATES IRON SENSING IN LIVERSINUSOIDAL ENDOTHELIAL CELLS
    person_pinHATI Debolina - National Institute of Health, Bethesda, United StatestopicCellular iron
    pageview
    15:30 | THE FXNI151F MOUSE MODEL OF FRIEDREICH ATAXIA PRESENTS TISSUE-DEPENDENTIRON HOMEOSTASIS ALTERATIONS
    person_pinPAZOS Maria - Dept. Ciències Mèdiques Bàsiques, Fac. Medicina, Universitat de Lleida. IRB Lleida., Lleida, SpaintopicCellular iron
    pageview
    15:45 | Iron-deficiency causes aspartate-sensitive metabolic dysregulation in CD8+ T-cells
    person_pinTEH Megan - MRC Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United KingdomtopicCellular iron
    pageview
    16:30 | COA DEFICIENCY ASTROCYTE MODEL HIGHLIGHT THE ROLE OF MITOCHONDRIAL IRON TRIGGERING NEURODEGENERATION
    person_pinLEVI Sonia - Vita-Salute San Raffaele University, Milano, Italy - IRCCS-San Raffaele Scientific Institute, Milan, ItalytopicIron in the heart & brain
    pageview
    16:45 | maternal iron deficiency impairs postpartum reversal of pregnancy-related cardiac remodelling.
    person_pinVERA-AVILES Mayra - University of Oxford, Oxford, United KingdomtopicIron in the heart & brain
    pageview
    17:00 | HEPCIDIN CHANGES IRON STATUS AND PREDICTS LONG-TERM OUTCOMES FOLLOWING MYOCARDIAL INFARCTION
    person_pinKABIR Syeeda Nashitha - University of Oxford, Oxford, United KingdomtopicIron in the heart & brain
    pageview
    17:15 | EXCHANGE PROTEIN DIRECTLY ACTIVATED BY CAMP 1, PROMOTES IRON-MEDIATED CARDIOMYOCYTE DEATH
    person_pinAGBEGBO Ezechiel - INSERM UMR 1297, TOULOUSE, FrancetopicIron in the heart & brain
    pageview
    09:30 | AUTOCRINE FUNCTION FOR HEPCIDIN IN KUPFFER CELLS DURING IRON OVERLOADING
    person_pinBLANCHET Margault - UMRS-1166, Paris, FrancetopicHepcidin regulation
    pageview
    09:45 | Role of Par2 and macrophages in hepcidin regulation
    person_pinBERGER Mathieu - INSERM U1220 Institut de recherche en santé digestive, Toulouse, FrancetopicHepcidin regulation
    pageview
    10:00 | Osteoblast-selective Erfe Deletion Confirms Cell-Autonomous Role of ERFE in the Bone homeostasis
    person_pinGINZBURG Yelena - Icahn School Of Medicine At Mount Sinai, New York, United StatestopicHepcidin regulation
    pageview
    10:15 | LOCALLY PRODUCED ARTICULAR HEPCIDIN IS ASSOCIATED WITH RHEUMATOID AND PSORIATIC ARTHRITIS
    person_pinLAMALLE Camille - INFINITY, Toulouse Institute for Infectious and Inflammatory Diseases, INSERM U1291, CNRS U5051, University Toulouse III, Toulouse, France, Toulouse, FrancetopicHepcidin regulation
    pageview
    11:00 | Activation of the BMP-SMAD pathway counteracts MASLD and its complications.
    person_pinSILVESTRI Laura - Vita-Salute San Raffaele University, Milan, Italy - Regulation of Iron Metabolism Unit, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, ItalytopicIron and liver diseases
    pageview
    11:15 | INTERPLAY OF HEME AND GLUCO-LIPID METABOLISM: IMPLICATIONS FOR LIVER PATHOPHYSIOLOGY
    person_pinAMMIRATA Giorgia - Molecular Biotechnology Center (MBC) “Guido Tarone”, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, ItalytopicIron and liver diseases
    pageview
    11:30 | ROLE OF FGL1 IN LIVER-RELATED METABOLIC DISEASES
    person_pinPERSONNAZ Jean - IRSD, Université de Toulouse, INSERM, INRAE, ENVT, Univ Toulouse III - Paul Sabatier (UPS), Toulouse, FrancetopicIron and liver diseases
    pageview
    11:45 | THE ROLE OF THE HEME-EXPORTER FLVCR1 IN HEPATOCELLULAR CARCINOMA
    person_pinDUARTE Tiago L - i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal - IBMC – Instituto de Biologia Molecular e Celular da Universidade do Porto, Porto, PortugaltopicIron and liver diseases
    pageview
    12:00 | CONSENSUS CRITERIA FOR METABOLIC HYPERFERRITINEMIA DIAGNOSIS AND GRADE IN A LARGE COHORT WITH MRI
    person_pinBARDOU-JACQUET Edouard - CHU Rennes, Rennes Cedex 9, FrancetopicIron and liver diseases
    pageview
    12:15 | TARGETING THE HEPATIC EPIGENETIC REGULATORS SUV420H1/2 TO COUNTERACT MASLD AND ITS COMPLICATIONS
    person_pinPAGANI Alessia - Division of Genetics and Cell Biology, IRCCS-Ospedale San Raffaele, Milano, Italy - Università Vita-Salute San Raffaele, Milano, ItalytopicIron and liver diseases
    pageview
    15:00 | Heme metabolism plays a critical role in sensitizing cells to ferroptosis
    person_pinRUBAN AGARVAS Anand - 1Department of Pediatric Hematology, Oncology and Immunology, University Hospital Heidelberg, Heidelberg, Germany - Molecular Medicine Partnership Unit, Heidelberg, GermanytopicCellular iron & ferroptosis
    pageview
    15:15 | JNK CONTROLS FERROPTOSIS BY MODULATING NCOA4-MEDIATED FERRITINOPHAGY
    person_pinFEDERICO Giorgia - Department of Molecular Medicine and Medical Biotechnology (DMMBM), University of Naples Federico II, via Sergio Pansini 5 80131, Naples, ItalytopicCellular iron & ferroptosis
    15:30 | Ferroptosis causes pancreatic failure in a mouse model of non-HFE hemochromatosis (FpnC326S)
    person_pinLE TERTRE Marlène - Center for translational biomedical iron research, Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, University Hospital Heidelberg, Heidelberg, GermanytopicCellular iron & ferroptosis
    pageview
    15:45 | THE NOVEL ORAL SMALL MOLECULE CPD-348 CLOSELY MIMICS HEPCIDIN AND AMELIORATES ERYTHROCYTOSIS IN MICE
    person_pinALT Carsten - Pfizer, South San Francisco, United StatestopicCellular iron & ferroptosis
    pageview
    16:30 | THE NATURAL HISTORY OF FERROPORTIN DISEASE - RESULTS OF THE INTERNATIONAL, MULTICENTER EASL NON-HFE
    person_pinTroppmair Maria - Medical University of Innsbruck, Department of Internal Medicine I, Gastroenterology, Hepatology and Endocrinology, Anichstrasse 35, 6020,, Innsbruck, AustriatopicHemochromatosis
    pageview
    16:45 | HAEMOCHROMATOSIS HFE GENOTYPES AND CLINICAL PENETRANCE TO OUTCOMES: LESSONS FROM THE UK BIOBANK
    person_pinATKINS Janice - Epidemiology and Public Health Group, Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, United KingdomtopicHemochromatosis
    pageview
    17:00 | Transient Elastography, Fib4 and APRI for the diagnosis of liver fibrosis in HFE hemochromatosis
    person_pinBARDOU-JACQUET Edouard - CHU Rennes, Rennes Cedex 9, FrancetopicHemochromatosis
    pageview
    17:15 | HEMATOLOGICAL SEQUELAE OF HFE P.C282C HOMOZYGISITY IN FOUR LARGE GENETIC COHORTS
    person_pinMAGNUSSON Magnus K - deCODE Genetics, & Faculty of Medicine, University of Iceland, Reykjavik, IcelandtopicHemochromatosis
    pageview
    P-01 - Laser Ablation coupled to ICP/MS provides multi-elemental resolutive spatial distribution in tissues
    person_pinLORÉAL Olivier - Elemental Analysis and Metal Metabolism platform (AEM2), University of Rennes, University Hospital, Rennes, France - INSERM, Univ Rennes, INRAe, UMR 1317, Nutrition, Metabolisms and Cancer Institute (NuMéCan), Rennes, France. , Rennes, FrancetopicIron related disorders
    pageview
    P-02 - FATIGUE IN PATIENTS WITH HEREDITARY HEMOCHROMATOSIS: A VALIDATION OF FATIGUE ASSESSMENT TOOLS
    person_pinSWIATCZAK Michal - Department of Cardiology and Electrotherapy, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, PolandtopicIron related disorders
    pageview
    P-03 - GLYCOSYLATED FERRITIN: A BIOMARKER TO HELP IN THE DIAGNOSIS OF FTL VARIANTS?
    person_pinCOUETTE Aurélien - Department of Biochemistry Toxicology, University Hospital, Rennes, FrancetopicIron related disorders
    pageview
    P-04 - Osteoporotic fracture risk is associated with higher plasma ferritin and serum iron level in females
    person_pinLOREAL Olivier - Univ Rennes, INSERM, Rennes University Hospital, UMR 1317, Institut NuMeCan (Nutrition Metabolisms and Cancer), Rennes, France. , Rennes, FrancetopicIron related disorders
    pageview
    P-05 - iron signature in pulmonary hypertension associated with chronic obstructive pulmonary disease
    person_pinMYRONENKO Oleh - Division of Pulmonology, Medical University of Graz, Graz, AustriatopicIron related disorders
    pageview
    P-06 - FUNCTIONAL TEST TO ASSESS THE IMPACT OF VARIANTS IDENTIFIED IN THE 3’UTR REGION
    person_pinDETIVAUD Lénaick - Laboratoire de Génétique Moléculaire et Génomique, Hôpital Pontchaillou CHU Rennes, 2 rue Henri Le Guilloux, 35000, Rennes, France - National Reference Center for Hemochromatosis and iron metabolism disorder, CHU Rennes, F-35000, Rennes, France., Rennes, France - Service des maladies du foie, Hôpital Pontchaillou CHU Rennes, 2 rue Henri Le Guilloux, 35000, Rennes, France - CNRS, Institut de génétique et développement de Rennes, Université de Rennes - UMR 6290, 35000, Rennes, FrancetopicIron related disorders
    pageview
    P-07 - ADDITIVE EFFECT OF MULTIPLE GENETIC VARIANTS IN SEC23B-PIEZO1 ON IRON METABOLISM DYSHOMEOSTASIS
    person_pinNOSTROSO Antonella - Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli ‘Federico II’, Napoli, Italy - CEINGE Biotecnologie Avanzate Franco Salvatore, Napoli, ItalytopicIron related disorders
    pageview
    P-08 - CONTRIBUTION OF FUNCTIONAL TESTS TO THE STUDY OF SPLICE VARIANTS IN IRON METABOLISM DISORDERS
    person_pinDETIVAUD Lénaick - Laboratoire de Génétique Moléculaire et Génomique, Hôpital Pontchaillou CHU Rennes, 2 rue Henri Le Guilloux 35000, Rennes, France - National Reference Center for Hemochromatosis and iron metabolism disorder, CHU Rennes, F-35000, Rennes, France - CNRS, Institut de génétique et développement de Rennes, Université de Rennes - UMR 6290,, Rennes, France - Service des maladies du foie, Hôpital Pontchaillou CHU Rennes, 2 rue Henri Le Guilloux, 35000, Rennes, FrancetopicIron related disorders
    pageview
    P-09 - TMPRSS6 NON-CODING VARIANTS IN IRIDA PHENOTYPE EXPRESSION IN MONOALLELIC AFFECTED INDIVIDUALS
    person_pinHOVING Vera - Department of Hematology, Radboud university medical center, Nijmegen, NetherlandstopicIron related disorders
    pageview
    P-10 - IRON OVERLOAD INDUCES GLUCOCORTICOID RESISTANCE IN MICE
    person_pinPAGANONI Rossana - University of Ulm, Ulm, GermanytopicIron related disorders
    pageview
    P-11 - BONE PHENOTYPING OF MURINE HEMOCHROMATOSIS MODELS WITH DEFICIENCIES OF HJV-, ALK2 OR ALK3
    person_pinDOGAN Deniz Yildirim - Department of Anesthesia, Intensive Care and Pain Medicine, Goethe University Frankfurt, Frankfurt am Main, GermanytopicSystemic iron regulation
    pageview
    P-12 - Ceruloplasmin and Ferroportin interaction in macrophage iron efflux
    person_pinPANZER Marlene - Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria - Christian Doppler Laboratory for Iron and Phosphate Biology, Medical University of Innsbruck, Innsbruck, AustriatopicSystemic iron regulation
    pageview
    P-13 - PROTEOMICS AS A SENSITIVE TOOL TO INVESTIGATE IRON HOMEOSTASIS REGULATING MECHANISMS
    person_pinKASTL Philipp - German Cancer Research Center (DKFZ), Heidelberg, GermanytopicSystemic iron regulation
    pageview
    P-14 - CHANGES IN IRON METABOLISM IN IRON-DEFICIENT/REPLETE PIGLETS AFTER SUCROSOMIAL® IRON SUPPLEMENTATION
    person_pinSTARZYNSKI Rafal - Institute of Genetics and Animal Biotechnology Polish Academy of Sciences, Magdalenka, PolandtopicSystemic iron regulation
    pageview
    P-15 - QUICK RECOVERY OF MOUSE PUPS FROM ANEMIA AFTER MATERNAL IRON DEFCIENCY DURING PREGNANCY
    person_pinLIPINSKI Pawel - Institute of Genetics and Animal Biotechnology Polish Academy of Sciences, Magdalenka, PolandtopicSystemic iron regulation
    pageview
    P-16 - ORAL SUCROSOMIAL® IRON IMPROVES IRON STATUS IN PREMATURE PIGLETS BORN BY CESAREAN DELIVERY
    person_pinSTARZYNSKI Rafal - Institute of Genetics and Animal Biotechnology PAS, Department of Molecular Biology, Laboratory of Iron Molecular Biology, Jastrzebiec, PolandtopicSystemic iron regulation
    pageview
    P-17 - PREMATURE BIRTH BY CESAREAN SECTION INFLUENCES IRON METABOLISM IN PIGLETS
    person_pinWANG Xiuying - Institute of Genetics and Animal Biotechnology PAS, Department of Molecular Biology, Laboratory of Iron Molecular Biology, Jastrzebiec, PolandtopicSystemic iron regulation
    pageview
    P-18 - EXPLORING THE CROSSTALK BETWEEN IRON HOMEOSTASIS AND ADIPOSE METABOLISM
    person_pinKARIN Gabriel - UCLA Center for Iron Disorders, Los Angeles, United StatestopicSystemic iron regulation
    pageview
    P-19 - MECHANISTIC INSIGHTS ON DIETARY IRON ABSORPTION: THE ROLES OF HEPCIDIN AND TRANSFERRIN
    person_pinPANTOPOULOS Kostas - Lady Davis Institute for Medical Research and McGill University, Montreal, CanadatopicSystemic iron regulation
    pageview
    P-20 - CHARACTERIZATION OF THE METALLOME OF EXTREME PHYSICAL INACTIVITY IN HUMANS AND RODENTS
    person_pinHOREAU Mathieu - Movement, Sport and Health Laboratory , Rennes , FrancetopicSystemic iron regulation
    pageview
    P-21 - Extreme physical inactivity affects differentially the iron metabolism in male and female rats
    person_pinHOREAU Mathieu - Movement, Sport and Health Laboratory - EA7470, University of Rennes, Rennes , FrancetopicSystemic iron regulation
    pageview
    P-22 - QUALITY OF LIFE AND FUNCTIONAL RESPONSE TO PERI-OPERATIVE ADMINISTRATION OF INTRAVENOUS IRON FOR THE
    person_pinMACLEAN Beth - School of Medicine, University of Western Australia, Perth, Australia - Department of Vascular Surgery, Fiona Stanley Hospital, Perth, AustraliatopicSystemic iron regulation
    pageview
    P-23 - DEVELOPING A SCREENING TOOL FOR IRON DEFICIENCY ANAEMIA DETECTION IN WOMEN DURING REPRODUCTIVE years
    person_pinMACLEAN Beth - School of Medicine, University of Western Australia, Perth, AustraliatopicSystemic iron regulation
    pageview
    P-24 - SLC7A7 DEFICIENCY CAUSES RENAL DYSFUNCTION AND REDUCED ERYTHROPOIETIN COMPROMISING ERYTHROPOIESIS
    person_pinBODOY Susanna - Universitat de Vic – Universitat Central de Catalunya, Vic, Spain - IRB Barcelona, Barcelona, Spain - Centro de Investigación Biomédica en Red en Enfermedades Raras , Madrid, SpaintopicErythropoiesis
    pageview
    P-25 - LENTIVIRAL GENE THERAPY RESCUES A NOVEL INDUCIBLE CODANIN-1 KO MOUSE MODEL OF BONE MARROW FAILURE
    person_pinRIVELLA Stefano - Children's Hospital of Philadelphia, Philadelphia, United States - University of Pennsylvania, Philadelphia, United StatestopicErythropoiesis
    pageview
    P-26 - EXPANDING THE MOLECULAR MECHANISMS AND THE PATIENT COHORT IN CONGENITAL DYSERYTHROPOIETIC ANEMIA III
    person_pinSANCHEZ Mayka - Department of Basic Sciences, Iron metabolism: Regulation and Diseases Group. Universitat Internacional de Catalunya (UIC), Barcelona, Spain - BloodGenetics S.L. Diagnostics in Inherited Blood Diseases. , Esplugues de Llobregat, SpaintopicErythropoiesis
    pageview
    P-27 - THE ROLE OF IRON IN THE INFLAMMATORY STAGE OF HETEROTOPIC OSSIFICATION
    person_pinSPANGENBERG Sven - Department of Medicine III & Center for Healthy Aging, Medical Faculty and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, GermanytopicIron and inflammatory disorders
    pageview
    P-28 - DIVIRGENT ROLE OF MACROPHAGE AND TUBULAR EPITHELIAL CELL IRON STATUS IN CHRONIC KIDNEY DISEASE
    person_pinAKCHURIN Oleh - Weill Cornell Medicine, New York, United StatestopicIron and inflammatory disorders
    P-29 - PLACENTAL PROTEINS INVOLVED IN IRON HOMEOSTASIS WERE DOWNREGULATED IN GESTATIONAL DIABETES MELLITUS
    person_pinJACOB Molly - Christian Medical College, Vellore, India, Vellore, IndiatopicIron and pregnancy
    pageview
    P-30 - Iron absorption and iron gains from birth to 6 months in breastfed and formula fed infants
    person_pinSTOFFEL Nicole - University of Oxford, Oxford, United Kingdom - ETH Zurich, Zurich, SwitzerlandtopicIron and pregnancy
    pageview
    P-31 - Estrogens and Prolactin Do Not Regulate Maternal and Embryo Iron Homeostasis During Pregnancy
    person_pinZHANG Vida - University of California, Los AngelestopicIron and pregnancy
    pageview
    P-32 - ASSOCIATION OF FERRITIN AND PLASMA IRON LEVELS AT TIME OF VACCINATION WITH THE IMMUNE RESPONSE TO SA
    person_pinMORETTI Diego - University of Applied Sciences of South Switzerland (SUPSI) / Swiss Distance University of Applied Sciences (FFHS), Zürich, SwitzerlandtopicIron and infection
    pageview
    P-33 - THE CROSS-TALK BETWEEN IMMUNITY AND ERYTHROPOIESIS IN MALARIA-INDUCED ANEMIA: THE ROLE OF HFE
    person_pinPÊGO Ana - NOVA Medical School, Lisbon, PortugaltopicIron and infection
    pageview
    P-34 - TRIGGERING THE SHIFT - SERUM IRON PROTEINS IN THE CROSSTALK BETWEEN IRON BIOLOGY AND IMMUNE RESPONSE
    person_pinFONSECA Óscar - i3S - Instituto de Investigação e Inovação em Saúde - Universidade do Porto, Porto, Portugal - Programa Doutoral em Biologia Molecular e Celular (MCBiology), Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, PortugaltopicIron and infection
    pageview
    P-37 - Dysregulated iron metabolism shapes alveolar macrophage response to Streptococcus pneumoniae in copd
    person_pinFAHERTY Lynne - School of Medicine, Trinity Biomedical Sciences Institute and Tallaght University Hospital, Trinity College Dublin, Dublin, IrelandtopicIron and infection
    pageview
    P-38 - IRON-SULFUR CLUSTER BIOGENESIS AND HEME METABOLISM ARE ESSENTIAL FOR RESIDUAL DISEASE IN AML
    person_pinSALAND Estelle - Inserm U1037, Toulouse, FrancetopicCellular iron homeostasis
    pageview
    P-39 - A ROLE FOR CD44 IN ERYHTROID IRON UPTAKE
    person_pinBESSON-FOURNIER Céline - IRSD, Université de Toulouse, INSERM, INRAE, ENVT, UPS, Toulouse, France, Toulouse, FrancetopicCellular iron homeostasis
    pageview
    P-40 - THE LINK OF FATTY ACID AND IRON METABOLISM IN THE CONTEXT OF TAMOXIFEN RESISTANCE
    person_pinTRUKSA Jaroslav - Institute of Biotechnology of the Czech Academy of Sciences, Vestec, CzechiatopicCellular iron homeostasis
    pageview
    P-41 - HYDROXYCINNAMIC ACID DERIVATIVES AS BIFUNCTIONAL ANTIOXIDANTS AND IRON CHELATORS FOR PHOTOPROTECTION
    person_pinPOURZAND Charareh - Life Sciences, University of bath, Bath, United Kingdom - Centre for Therapeutic Innovation, University of Bath, Bath, United Kingdom - Centre for Bioengineering and Biomedical Technologies, University of Bath, Bath, United KingdomtopicCellular iron homeostasis
    pageview
    P-42 - THE UNEXPECTED LINK BETWEEN IRON REGULATION AND HYPOSPERMATOGENESIS
    person_pinHARRER Aileen - Institute of Anatomy and Cell Biology, Unit of Reproductive Biology, Justus-Liebig-University of Giessen, Giessen, GermanytopicCellular iron homeostasis
    pageview
    P-43 - IRON REGULATION IN SKELETAL MUSCLE DIFFERS DEPENDING ON MUSCLE WASTING AND IRON OVERLOAD CONDITIONS
    person_pinAUFFRET Maëlys - Laboratory “Movement Sport and Health Sciences” (M2S), EA7470, University Rennes 2, Rennes, FrancetopicCellular iron homeostasis
    pageview
    P-44 - UNRAVELING HFE-INTERACTION PARTNERS AND SIGNALLING: IMPACT ON CELLULAR IRON HOMEOSTASIS
    person_pinSTEGEMANN Gaby - Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre (AUMC), University of Amsterdam, Amsterdam, NetherlandstopicCellular iron homeostasis
    pageview
    P-45 - IRON LOADING IN ALVEOLAR MACROPHAGES ALTERS ALVEOLAR TYPE II EPITHELIAL CELL FUNCTION IN COPD
    person_pinWUGK Sophia - Trinity College Dublin, Dublin, IrelandtopicCellular iron homeostasis
    pageview
    P-46 - Exploring Iron Dynamics in Alveolar Type II Epithelial Cells: Implications in Chronic Lung Diseases
    person_pinKENNY Sarah - School of Medicine, Trinity Biomedical Sciences Institute and Tallaght University Hospital, Trinity College Dublin., Dublin, IrelandtopicCellular iron homeostasis
    pageview
    P-47 - THE SIRES (SEARCHING FOR IRON RESPONSIVE ELEMENTS) SOFTWARE IS BACK
    person_pinSANCHEZ Mayka - Department of Basic Sciences, Iron metabolism: Regulation and Diseases Group. Universitat Internacional de Catalunya (UIC), Barcelona, SpaintopicCellular iron homeostasis
    pageview
    P-48 - EXPLORING THE ROLE OF TRANSFERRIN RECEPTOR 1 IN BONE HOMEOSTASIS
    person_pinPASSIN Vanessa - Department of Medicine III & Center for Healthy Aging, Medical Faculty and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, GermanytopicCellular iron homeostasis
    pageview
    P-49 - BRAIN IRON AND RISK OF DEMENTIA AND PARKINSON'S DISEASE: A GENETIC ANALYSIS IN THE UK BIOBANK COHORT
    person_pinCASANOVA Francesco - Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, United KingdomtopicIron in the brain
    pageview
    P-50 - A POTENTIAL ROLE OF PHOSPHORYLATION IN CERULOPLASMIN STABILITY AND ACTIVITY
    person_pinMAGHERINI Giulio - University of Siena, Siena, Italy - Kedrion Biopharma, Lucca, ItalytopicIron in the brain
    pageview
    P-51 - MUSCULAR ADAPTATIONS TO IRON DEFICIENCY ANEMIA AND THE REVERSIBILITY AFTER INTRAVENOUS IRON
    person_pinPERTLER Elke - Christian Doppler Laboratory for Iron and Phosphate Biology, Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria - Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, AustriatopicIron in the heart
    pageview
    P-52 - THE FAILING HEART SHOWS A PATTERN OF IRON ACCUMULATION IN FIBROTIC AREAS
    person_pinMERTENS Christina - Department of Pediatric Hematology, Oncology and Immunology, Heidelberg University Hospital, Heidelberg, Germany - Center for Translational Biomedical Iron Research, Heidelberg, Germany - German Centre for Cardiovascular Research (DZHK), partner site Heidelberg/Mannheim, GermanytopicIron in the heart
    pageview
    P-53 - MYOCARDIAL LABILE IRON DYNAMICS IN ACUTE AND CHRONIC IRON OVERLOAD
    person_pinLIM Dillon Yee - Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United KingdomtopicIron in the heart
    pageview
    P-54 - IRON OVERLOAD IN HUMAN IPS CARDIOMYOCYTES
    person_pinSEEBOHM Guiscard - Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, Münster, GermanytopicIron in the heart
    pageview
    P-56 - FK506 BYPASSES THE EFFECT OF ERYTHROFERRONE IN CANCER CACHEXIA SKELETAL MUSCLE ATROPHY
    person_pinMINA Erica - Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center "Guido Tarone", University of Torino, Turin, ItalytopicPharmaceutical treatments
    pageview
    P-57 - MYELODYSPLASTIC SYNDROMES BENEFIT FROM IRON-RESTRICTED BONE MARROW TRANSPLANT IN PRECLINICAL MODEL
    person_pinVINCHI Francesca - New York Blood Center, New York , United StatestopicPharmaceutical treatments
    pageview
    P-58 - PHARMACOKINETICS AND PHARMACODYNAMICS OF AN ANTI-TMPRSS6 MONOCLONAL ANTIBODY IN MICE.
    person_pinGIANNINI Silvia - Disc Medicine, Watertown, United StatestopicPharmaceutical treatments
    pageview
    P-59 - DEFINING IRON DEFICIENCY IN RCTS: META-ANALYSIS OF THE TREATMENT EFFECT OF IV IRON
    person_pinMACLEAN Beth - The University of Western Australia, Perth, AustraliatopicPharmaceutical treatments
    pageview
    P-60 - THE USE OF DEFERIPRONE TO ALLEVIATE IRON LOADING IN MURINE ALVEOLAR-LIKE MACROPHAGES
    person_pinJORDAN Ruaraidhri - School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, and Tallaght University Hospital, Dublin , IrelandtopicPharmaceutical treatments
    pageview
    P-61 - THE FERROPORTIN INHIBITOR CPD-348 AMELIORATES THALASSEMIA SYMPTOMS IN HBB(TH3/+) MICE
    person_pinALT Carsten - Pfizer, South San Francisco, United StatestopicPharmaceutical treatments
    pageview
    P-62 - FERROPTOSIS IN THE HEART TISSUE OF PATIENTS WITH ATRIAL FIBRILLATION
    person_pinBALUSIKOVA Kamila - Centre for Research on Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University, Prague, CzechiatopicFerroptosis
    pageview
    P-64 - Deciphering ferroptosis in mucopolysaccharidosis III (MPSIIIB) mouse model
    person_pinLARRIBAU Mathilde - Institute for Infectious and Inflammatory Diseases (Infinity)- INSERM U1291, 31024 Toulouse, FrancetopicFerroptosis
    pageview
    P-66 - ATR inhibitor camonsertib (RP-3500) suppresses early-stage erythroblasts by mediating ferroptosis
    person_pinGINZBURG Yelena - Icahn School Of Medicine At Mount Sinai, New York, United StatestopicFerroptosis
    pageview
    P-67 - Development of peptide-based tools to measure cellular free heme after UVA irradiation
    person_pinGAO Nan - Department of Life Sciences, University of Bath, Bath, United KingdomtopicHeme
    pageview
    P-68 - A HEME-DEPENDENT MITOCHONDRIAL FAILURE CONTRIBUTES TO THE PATHOGENESIS OF FLVCR1-RELATED DISEASES.
    person_pinZANIN VENTURINI Diletta Isabella - Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, ItalytopicHeme
    pageview
    P-69 - UNRAVELING IRON METABOLISM IN CANCER: INSIGHTS INTO FLVCR1A AND HEME BIOSYNTHESIS
    person_pinFIORITO Veronica - Molecular Biotechnology Center “Guido Tarone”, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy - These authors contributed equally to this work, ., ItalytopicHeme
    pageview
    P-70 - Early diagnosis of aceruloplasminemia in infancy through NGS sequencing
    person_pinAguilar Martinez1 Patricia - Laboratory of hematological biology and expert center on rare iron disorders, Hôpital Saint Eloi, CHU of Montpellier, Montpellier, FrancetopicHemochromatosis
    pageview
    P-71 - BONE DEFICITS IN RESPONSE TO IRON ADMINISTRATION BETWEEN HFE HEMOCHROMATOSIS AND WILDTYPE MICE
    person_pinSTEELE-PERKINS Peter - University Ulm, Ulm, GermanytopicHemochromatosis
    pageview
    P-72 - CONSENSUS INITIATIVE FOR THE DEFINITION OF PHENOTYPIC DIAGNOSTIC CRITERIA FOR HEMOCHROMATOSIS
    person_pinTROPPMAIR Maria Rosina - Medical University of Innsbruck, Innsbruck, AustriatopicHemochromatosis
    pageview
    P-73 - Haemochromatosis HFE genotypes and chondrocalcinosis: Early data from analysis in UK Biobank
    person_pinBANFIELD Lucy - The Department of Health and Care Professions, Faculty of Health and Life Sciences, University of Exeter, Exeter, United KingdomtopicHemochromatosis
    pageview
    P-75 - ALBUMIN MODIFICATION IN HEMOCHROMATOSIS
    person_pinSILVA André - LAQV-REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal - LAQV-REQUIMTE, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, PortugaltopicHemochromatosis
    pageview
    P-76 - TRANSFERRIN IRON-LOBE DISTRIBUTION AND POST-TRANSLATIONAL MODIFICATIONS IN HEMOCHROMATOSIS
    person_pinRAMOS Eduardo - LAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Portugal, Porto, PortugaltopicHemochromatosis
    pageview
    P-77 - CENTRAL ADIPOSITY AND HAEMOCHROMATOSIS CLINICAL PENETRANCE IN HFE P.C282Y HOMOZYGOTES IN UK BIOBANK
    person_pinLUCAS Mitchell - University of Exeter, Exeter, United KingdomtopicHemochromatosis
    pageview
    P-78 - THE ROLE OF THE HEMOCHROMATOSIS PROTEIN HFE IN MACROPHAGE METABOLISM
    person_pinKNOOP Paul - University Ulm, Ulm, GermanytopicHemochromatosis
    pageview
    P-79 - CLINICAL AND GENETIC CHARACTERISTICS OF A PROSPECTIVENONHFE C282Y HEMOCHROMATOSIS COHORT
    person_pinBARDOU-JACQUET Edouard - CHU Rennes, Rennes Cedex 9, FrancetopicHemochromatosis
    pageview
    P-80 - BONE MARROW TFR2 DELETION COOPERATES WITH ACTIVIN LIGAND TRAP RAP-536 IN AMELIORATING β-THALASSEMIA
    person_pinTANZI Emanuele - Regulation of Iron Metabolism Unit, Division of Genetics and Cell Biology, IRCCS Ospedale San Raffaele, Milan (Italy), Milano, Italy - Vita-Salute San Raffaele University, Milan (Italy), Milano, ItalytopicHemochromatosis
    pageview
    P-81 - TMPRSS6 INHIBITION IMPROVES BONE HEALTH IN B-THALASSEMIA MICE
    person_pinCROWELL Beth - Regeneron Pharmaceuticals, Tarrytown, United StatestopicHemochromatosis
    pageview
    P-82 - Intestinal ferroportin protein expression in murine models of hemojuvelin overexpression
    person_pinHORNUNG Isabelle - Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, GermanytopicHepcidin regulation
    pageview
    P-83 - THE MAPK AND NRF2 PATHWAYS ACT IN CONCERT TO CONTROL IRON-INDUCED BMP6 EXPRESSION IN LIVER SINUSOIDA
    person_pinQIU Ruiyue - Department of Pediatric Oncology, Hematology and Immunology and Hopp Children Cancer Center (KiTZ), University Hospital Heidelberg, Heidelberg, GermanytopicHepcidin regulation
    pageview
    P-84 - HYPOXIA DOWREGULATES HEPCIDIN AND UPREGULATES FGL1 EXPRESSION IN MICE
    person_pinKRIJT Jan - Institute of Pathological Physiology, First Faculty Of Medicine, Charles University, Prague, CzechiatopicHepcidin regulation
    pageview
    P-85 - PHARMACOKINETICS AND PHARMACODYNAMICS OF AN ANTI-HEMOJUVELIN MONOCLONAL ANTIBODY IN MICE
    person_pinWU Min - DISC Medicine, Watertown, United StatestopicHepcidin regulation
    pageview
    P-86 - A PHASE 1B TRIAL OF DISC-0974, AN ANTI-HEMOJUVELIN ANTIBODY, IN PATIENTS WITH MYELOFIBROSIS AND ANEM
    person_pinWU Min - Disc Medicine, Watertown, United StatestopicHepcidin regulation
    pageview
    P-87 - PIEZO1 GAIN-OF-FUNCTION VARIANTS REGULATE HEPCIDIN EXPRESSION BY MODULATING mTOR/LAMTOR4 SIGNALLING
    person_pinROSATO Barbara Eleni - Department of Molecular Medicine and Medical Biotechnology, University of Naples 'Federico II', Naples, Italy., Naples, Italy - CEINGE Advanced Biotechnology Franco Salvatore, Naples, Italy., Naples, ItalytopicHepcidin regulation
    pageview
    P-88 - THE INFLUENCE OF DIETARY CONTAMINATION WITH AFLATOXIN AFB1 ON BASIC INDICATORS OF IRON METABOLISM
    person_pinOGLUSZKA Magdalena - Department of Genomics, Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Jastrzebiec, PolandtopicIron in liver diseases
    pageview
    P-89 - UNRAVELLING THE ROLE OF SUV420H2 IN A MOUSE MODEL OF OBESITY, INSULIN RESISTANCE, AND T2DM
    person_pinCARLEO Rossana - Regulation of Iron Metabolism Unit, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, ItalytopicIron in liver diseases
    pageview
    P-90 - Hepatocyte-specific inactivation of the epigenetic regulator SUV420H1 improves MASLD in mice
    person_pinPAGANI Alessia - IRCCS-Ospedale San Raffaele, Milano, Italy - Vita-Salute San Raffaele University, Milano, ItalytopicIron in liver diseases
    pageview
    P-91 - STEATOSIS CAUSES HEPATIC IRON RESISTANCE IN TYPE 2 DIABETES.
    person_pinALTAMURA Sandro - University of Heidelberg - Kinderklinik, Heidelberg, GermanytopicIron in liver diseases
    pageview
  •  General Organisation
    INSIGHT OUTSIDE
    26 av Jean Kuntzmann
    38330 Montbonnot Saint-Martin
    Tel : +33 825 595 525 (0,15€/min*)
    Information desk
    monday to friday from 2pm to 5pm
    ORGANISATION
    INSERM
    101, rue de Tolbiac –
    75654 Paris Cedex 13

    CHU Purpan 
    Place du Docteur Baylac 
    CS 60039 - 31024 Toulouse Cedex 3
    (*) Prices starting from fixed line incumbent, a surcharge may be applied by operators, counting the second after the first 45 seconds.

    According to France's Personal Data Privacy Act in effect since June 2004, you may send a request in writing to INSIGHT OUTSIDE 26 Avenue Jean Kuntzmann, 38330 - Montbonnot Saint Martin / France, or by email webmaster@insight-outside.fr to access your file in order to consult, modify and/or delete your personal information.

    © 2005 - 2023 Insight Outside